Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis.
Tang P, Chen X, Xu J, Hu Y, Ye Z, Wang X, Xiao Y, Shen X, Zhang J, Feng Y, Shi C, Yu X, Yi L, Chen X, Lu B, Xu P, Sun Z, Wu M.
Tang P, et al. Among authors: wu m.
J Immunol Res. 2022 Mar 17;2022:2943113. doi: 10.1155/2022/2943113. eCollection 2022.
J Immunol Res. 2022.
PMID: 35340584
Free PMC article.